Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
aerosolized, affirmative, ahead, airway, American, antibody, batch, Berlin, bivalent, cGMP, challenging, clearance, Companay, composition, database, demand, differentiated, dominated, drew, Economy, endemic, ESWI, evolving, exceeded, face, facing, factory, ferret, flow, fluctuate, fragmented, GMP, immunological, ivacaftor, journal, key, Kieth, Kummerfeld, Lancet, large, lock, MAA, manuscript, maximum, modulator, mucociliary, negligible, neighboring, North, older, oOn, persistence, pivotal, plasmid, poster, preliminary, President, progression, prompt, pseudoviral, published, pulmonary, Regulation, repaid, Senior, subvariant, superior, superiority, template, transfection, trend, UGX, Valencia, vary, version, Vice, yearly
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view